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  
Abstract— Objective: To investigate the etiology of bile duct 
dilatation and proportion of each cause. Methods: A 
retrospective study was performed by classification on clinical 
data collected from 1430 patients with bile duct dilatation in our 
hospital from January 2000 to December 2013.  Results: There 
were 90 patients with congenital bile duct cysts (6.3%) and 1340 
with secondary bile duct dilatation (93.7%). In total, 22 
categories of causes were identified. Among them, the top five 
were bile duct stones (n=476, 33.3%), pancreatic head 
carcinoma (n=179, 12.5%), periampullary carcinoma (n=159, 
11.9%), cholangiocarcinoma (n=89, 6.2%), and chronic 
pancreatitis or pancreatic head cyst (n=80, 5.6%). Conclusion: 
The causes of bile duct dilatation can be classified into 
congenital and secondary categories. The former accounted for 
approximately 6.0% and the latter for approximately 94%. The 
most common causes were bile duct stones, pancreatic head 
carcinoma and periampullary carcinoma. 
 
Index Terms— Bile Duct Dilatation; Etiology; Classification; 
Proportion. 
I. INTRODUCTION 
  Normal diameter of common bile duct is <8 mm. A 
common bile duct diameter ≥8 mm at its widest point is 
called common bile duct dilatation. Normally, the diameter of 
right hepatic duct is 3.5 mm and that of left hepatic duct is 3.3 
mm. The condition with a diameter of left or right hepatic 
duct exceeding the normal range is called intrahepatic bile 
duct dilatation [1]. Generally, but not absolutely, extrahepatic 
bile duct dilatation occurs before intrahepatic bile duct 
dilatation. Hilar or intrahepatic lesions can cause intrahepatic 
bile duct dilatation without extrahepatic bile duct dilatation. 
    Bile duct dilatation is common in clinical practice. Many 
patients come to the hospital because of bile duct dilatation. 
Some causes are obvious and some are subtle.  In order to 
fully understand and investigate the causes of bile duct 
dilatation and proportion of each cause, develop a 
comprehensive and accurate diagnosis strategy,  and identify 
effective treatment options in a timely manner, clinical data 
collected from 1430 patients with bile duct dilatation in our 
hospital from January 2000 to December 2013 were analyzed 
by classification. The results are summarized as follows. 
II. CLINICAL DATA 
The 1430 patients enrolled included 876 males and 554 
females, with a male to female ratio of 1.6: 1, and were aged 
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14-85 years, with a mean age of 56 years. All the patients 
underwent B ultrasound, CT or MRI, 233 (16.3%) underwent 
endoscopic retrograde cholangiopancreatography (ERCP), 
and 80 (5.6%) underwent upper gastrointestinal barium meal 
examination and endoscopy. Bile duct dilatation was found in 
1315 patients (92.0%) in preoperative diagnosis and in 115 
patients (8.0%) during intraoperative exploration. All 
patients underwent surgery. Surgical procedures were 
selected according to the specific cause. For example, 
patients with stones underwent choledocholithotomy and 
T-tube drainage; those with cholangiocarcinoma underwent 
resection of cholangiocarcinoma; and those with pancreatic 
head carcinoma underwent pancreaticoduodenectomy. 
 
III. RESULTS 
The causes of bile duct dilatation and proportion of each 
cause in 1430 patients are shown in Table 1. 90 patients 
(6.3%) had congenital bile duct cysts, with the maximum cyst 
size of 100 mm × 150 mm and the minimum size of 10 mm × 
15 mm. 1340 patients (93.7%) had secondary bile duct 
dilatation, of which 374 patients  (27.90%) had a common 
bile duct diameter of 8 mm-12 mm, 478 (35.6%) of 12 mm - 
16 mm, 240 (17.9%) of 16 mm - 20 mm, and 248 (18.5%) of 
>20 mm. Degree of bile duct dilatation caused by different 
causes is shown in Table 2. The relationship between the 
degree of secondary common bile duct dilatation from the top 
five causes and the serum total bilirubin is shown in Table 3. 
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                                Table 1 Causes of bile duct dilatation in 1430 patients 
 
 
 
 
 
 
Cause           Case number       % Cause              Case number      %    
Congenital bile duct cysts   90         6.3 
Choledocholithiasis       476         33.3   
After cholecystectomy     51         3.6 
Biliary parasites          51         3.6 
Cholangitis              53         3.7 
Bile duct stricture         14         1.0 
Extrahepatic 
cholangiocarcinoma       89         6.2 
Mirizzi Syndrome        10         0.7 
Hemobilia              10         0.7 
Constrictive papillitis      9         0.6 
Duodenal papillary 
carcinoma              40         2.8 
Oddi sphincter relaxation        6        0.4 
Bilioenteric anastomotic 
stricture                      15        1.0 
Chronic cholecystitis with  
impacted stones in the  
neck of gallbladder             28        2.0 
Gallbladder carcinoma          30        2.1 
Periampullary carcinoma        159       11.1 
Pancreatic head carcinoma       179       12.5 
Hilar metastases                17        1.2 
Chronic pancreatitis or  
pancreatic head cysts           80        5.6 
Duodenal bulb ulcers           16        1.1 
Parapapillary diverticulitis       4        0.3 
Duodenal obstruction           3        0.2 
  
Table 2 Causes and degree (mm) of secondary bile duct dilatation in 1340 patients 
   
  8.0-12.0 12.0-16.0 16.0-20.0 >20.0 
Cause Case number N     % N     % N    % N     % 
Choledocholi
thiasis 
476 91  19.1  201   42.2  145   30.5  39   8.2 
After 
cholecystecto
my 
  51 41  80.4 10   19.6 0 0 
Biliary 
parasites 
  51 43   84.3  8   15.7 0 0 
Cholangitis   53  8   15.1  23   43.4  13   24.5  9   17.0 
Extrahepatic 
cholangiocar
cinoma 
  89   29   32.6  18   20.2 17   19.1 25   28.1 
Mirizzi 
Syndrome 
  10  1   10.0  5   50.0 3   30.0   1   10.0 
Hemobilia   10  4   40.0  5   50.0  1   10.0 0 
Constrictive 
papillitis 
  9  3   33.3   4   44.5 2   22.2 0 
Duodenal 
papillary 
carcinoma 
  40  4   10.0   7   17.5 23   57.5    6   15.0 
Oddi 
sphincter 
relaxation 
   6  3   50.0  2   33.3 1   16.7 0 
Bilioenteric 
anastomotic 
stricture 
  15  4   26.7  7   46.6 4   26.7 0 
Chronic 
cholecystitis 
  28 20   71.4   7   25.0 1    3.6 0 
Gallbladder 
carcinoma 
  30 10   33.3  12   40.0 5    16.7 3    10.0 
Periampullar
y carcinoma 
159   17   10.7  66   41.5  59   37.1 17    10.7 
Pancreatic 
head 
carcinoma 
179  42   23.5   69   38.5  41   22.9 27    15.1 
Hilar 
metastasis 
 17 
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Chronic 
pancreatitis 
 80  40   50.0  20   25.0  14   17.5   6    7.5 
Duodenal 
obstruction 
 3  2    66.7   1   33.3 0 0 
Parapapillary 
diverticulitis 
 4 3    75.0   1   25.0 0 0 
Duodenal 
bulb ulcer 
Bile duct 
stricture 
Total 
 16 
 
 14 
 
1340 
 10   62.5 
 
 4    28.6 
 
380   28.4 
  5   31.3 
 
  5   35.7 
 
479   35.7 
 1    6.2 
 
  3    21.4 
 
341   25.4 
0 
 
 2    14.3 
 
140   10.5 
 
Table 3 The relationship between the degree of common bile duct dilatation from the top five causes and the serum total 
bilirubin (μmol/L) 
 
 Bile duct 
dilatation 
＜30 30.1-68.3 68.4-171 >171 
Cause (mm) N     % N     % N    % N    % 
Choledocholi
thiasis 
 (n=476) 
8.0-12.0 
12.1-16.0 
16.1-20.0 
>20.0 
Subtotal 
12    2.5 
72   15.1 
 7    1.5 
14    2.9 
 105   22.1 
20    4.2 
 86   18.1 
  7   1.5 
 44   9.2 
157  33.0 
20    4.1 
23    4.9 
13    2.7 
44    9.2 
100    21.0 
40    8.4 
21    4.4 
13    2.7 
40    8.4 
114   23.9 
Pancreatic 
head 
carcinoma 
(n=179) 
8.0-12.0 
12.1-16.0 
16.1-20.0 
>20.0 
 Subtotal         
  13  7.3      13     
7.3  19      10.6 
 13    7.3  
58     32.4 
  4     2.2 
 7  3.9    
 3   1.7 
 3    1.7 
17    9.5 
12    6.7 
16    8.9 
12    6.7 
8     4.5 
48   26.8 
 13    7.3 
 32   17.9 
  7   3.9 
  4   2.2 
56   31.3 
Periampullar
y carcinoma 
(n=159) 
8.0-12.0 
12.1-16.0 
16.1-20.0 
>20.0 
Subtotal 
 8     5.0 
 2     1.3 
 8  5.0       
     0 
 18    11.3 
0 
9    5.7 
0 
0 
9    5.7 
0 
23   14.5 
4     2.5 
7     4.4 
34    21.4 
9      4.9 
33    20.5 
46    29.5 
10     6.5 
98    61.6 
Extrahepatic 
cholangiocar
cinoma 
(n=89) 
8.0-12.0 
12.1-16.0 
16.1-20.0 
>20.0 
Subtotal 
12    13.50 
0 
0 
0 
12    13.5 
 0      
 4     4.5 
 2     2.2  
 6     6.7 
12    13.5 
5    5.6 
 9   10.1 
1    1.1 
3    3.4 
18   20.2 
12   13.5 
  5    5.6 
 15    16.9 
 15   16.9 
47   52.8 
Chronic 
pancreatitis 
(n=80) 
8.0-12.0 
12.1-16.0 
16.1-20.0 
>20.0 
Subtotal 
36    45.0 
10    12.5 
10    12.5 
0 
56   70.0 
4     5.0 
4     5.0 
2     2.5 
2     2.5 
12    15.0 
0 
 5      6.3 
 2      2.5 
 5      6.3 
12     15.0 
 0 
 0 
 0 
 0 
 0 
 
 
IV.  DISCUSSION 
Bile duct dilatation is not only a clinical symptom of many 
diseases, but also a sign. There are many conditions that can 
cause bile duct dilatation and they can be divided into 
congenital and secondary categories. Congenital biliary 
dilatation (cysts), which is congenital bile duct abnormalities 
[2], accounted for about 6% of the causes. It was first reported 
by German Abrahan veter in 1713, then supplemented and 
improved by F.Alonso-lej, Caroli, Longmire and other 
researchers, and finally classified into five types [3]. This 
classification is still regarded as a classic and the treatment is 
also very mature [4]. Secondary bile duct dilatation, also 
known as postnatal or acquired bile duct dilatation, is very 
common in clinical practice, accounting for 94% of the 
causes. It is secondary to some diseases or acquired factors. 
An intrahepatic bile duct diameter of 5 mm is called mild 
dilatation of intrahepatic bile duct, 5-9 mm called moderate 
dilatation, and >9 mm called severe dilatation. A common 
bile duct diameter of 8-12 mm is called mild dilatation, 
accounting for approximately 28.4%, 12-16 mm called 
moderate dilatation, accounting for approximately 35.7%, 
16-20 mm called severe dilatation, accounting for 
approximately 25.4%, and >20 mm called extremely severe 
dilatation, accounting for approximately 10.5% [1].  
      Mild to moderate biliary dilatation is commonly found in 
post-cholecystectomy patients, and patients with biliary 
parasites, chronic cholecystitis with impacted cervical stones, 
Oddi sphincter relaxation [5], traction and compression caused 
by duodenal bulb ulcers, pancreatic head carcinoma, chronic 
pancreatitis or pancreatic head cysts, and general common 
bile duct stones. Serious to extremely serious dilatation is 
mostly seen in patients with sand-like stones, cone-shaped 
stones or impacted stones in the lower segment of common 
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bile duct, traumatic biliary stricture, and carcinoma, including 
cholangiocarcinoma, hilar metastasis, periampullary 
carcinoma, and pancreatic head carcinoma. The top five 
causes of secondary bile duct dilatation were bile  
duct stones (n=476, 33.3%), pancreatic head carcinoma 
(n=179, 12.5%), periampullary carcinoma (n=159, 11.9%), 
cholangiocarcinoma (n=89, 6.2%), and chronic pancreatitis 
or pancreatic head cyst (n=80, 5.6%). 
      There is a certain relationship between the top five causes 
and serum bilirubin.  Generally, in bile duct dilatation caused 
by carcinoma, the more severe the bile duct dilatation, the 
higher the level of serum bilirubin. The absence of jaundice in 
bile duct dilatation caused by carcinoma is not only 
associated with early detection of lesions and incomplete 
obstruction of bile duct, but also associated with whether the 
carcinoma directly originates from the bile duct wall or just 
compresses the bile duct wall. For example, since 
cholangiocarcinoma directly originates from the bile duct 
wall, it tends to progress and cause bile duct stricture, and 
over 86% of patients with cholangiocarcinoma had jaundice 
[6], with a serum total bilirubin level of >30 μmol/L; 
pancreatic head carcinoma compress the bile duct to exert an 
indirect effect in most cases, and will not cause serious bile 
duct stricture if the contralateral bile duct is elastic, so that 1/3 
of patients with pancreatic head carcinoma do no have 
jaundice. In addition, in some cases, although carcinoma is 
detected late, the flow of bile is not affected since necrosis 
has occurred at the center of carcinoma to form a tunnel, so 
that the patient may not have jaundice. 
    Bile duct dilatation caused by choledocholithiasis is 
complex. As shown in Figure 1, 22.1% of patients with 
common bile duct stones had almost no jaundice (serum total 
bilirubin< 30 μmol/L) in clinical practice. Of them, 14 
patients had a common bile duct diameter of >20 mm, 
accounting for approximately 10% of all patients with a 
common bile duct diameter >20 mm (14/142). This indicated 
that the degree of common bile duct dilatation is not 
proportional to incidence of jaundice in these patients. 
Patients with common bile duct dilatation do not necessarily 
have jaundice. It may be because of the flow of bile through 
gaps between stones into the duodenum. The bile duct 
pressure is presumably not high. Bile duct dilatation caused 
by choledocholithiasis is the gradual expansion bile duct 
during stone formation [1]. The flow of bile through gaps 
between stones into the duodenum is affected by many 
factors, such as the size, shape, number, and location of 
stones. If there are cone-shaped stones or impacted stones in 
the terminal segment of common bile duct, the gaps between 
stones will disappear, and the bile can not flow into the 
duodenum. In this case, the degree of common bile duct 
dilatation is proportional to the incidence of jaundice. 70% of 
patients with bile duct dilatation caused by chronic 
pancreatitis did not have jaundice; and even in those with 
jaundice, serum total bilirubin did not exceed 171 μmol/L at 
most. 
      In summary, secondary bile duct dilatation can be divided 
into six types according to bile duct pressure and cause. 
      From the benign and malignant perspective, it can be 
divided into bile duct dilatation caused by benign lesions and 
that caused by malignant lesions. From the functional and 
organic perspective, it can be divided into bile duct dilatation 
caused by functional disturbance and that caused by organic 
lesions. 
      In addition, secondary bile duct dilatation can be divided 
into obstructive and non-obstructive types, depending on 
whether the bile duct is obstructive. The obstructive type 
includes bile duct dilatation caused by stones, parasites, 
polyps, tumors, ectopic pancreas or other obstructions; and 
the non-obstructive type includes bile duct dilatation caused 
by bile duct compression (e.g., caused by peribiliary 
aneurysm, acute and chronic pancreatitis, pancreatic 
pseudocyst, pancreatic head carcinoma, parapapillary 
diverticulitis, compression from metastasis, ectopic pancreas 
in duodenum partition, and duodenal postbulbar ulcers), bile 
duct stricture, constrictive papillitis, bilioenteric anastomotic 
stricture, and pancreatic and bile duct junction injuries [14]. 
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